全文获取类型
收费全文 | 21798篇 |
免费 | 1553篇 |
国内免费 | 79篇 |
专业分类
耳鼻咽喉 | 216篇 |
儿科学 | 465篇 |
妇产科学 | 347篇 |
基础医学 | 2909篇 |
口腔科学 | 460篇 |
临床医学 | 2183篇 |
内科学 | 4539篇 |
皮肤病学 | 210篇 |
神经病学 | 2221篇 |
特种医学 | 780篇 |
外科学 | 3077篇 |
综合类 | 439篇 |
一般理论 | 20篇 |
预防医学 | 1998篇 |
眼科学 | 585篇 |
药学 | 1574篇 |
1篇 | |
中国医学 | 45篇 |
肿瘤学 | 1361篇 |
出版年
2023年 | 72篇 |
2022年 | 128篇 |
2021年 | 378篇 |
2020年 | 203篇 |
2019年 | 369篇 |
2018年 | 388篇 |
2017年 | 307篇 |
2016年 | 318篇 |
2015年 | 460篇 |
2014年 | 547篇 |
2013年 | 903篇 |
2012年 | 1290篇 |
2011年 | 1328篇 |
2010年 | 746篇 |
2009年 | 701篇 |
2008年 | 1208篇 |
2007年 | 1383篇 |
2006年 | 1438篇 |
2005年 | 1459篇 |
2004年 | 1321篇 |
2003年 | 1274篇 |
2002年 | 1242篇 |
2001年 | 303篇 |
2000年 | 273篇 |
1999年 | 303篇 |
1998年 | 264篇 |
1997年 | 265篇 |
1996年 | 191篇 |
1995年 | 206篇 |
1994年 | 187篇 |
1993年 | 183篇 |
1992年 | 203篇 |
1991年 | 164篇 |
1990年 | 181篇 |
1989年 | 177篇 |
1988年 | 219篇 |
1987年 | 152篇 |
1986年 | 177篇 |
1985年 | 167篇 |
1984年 | 178篇 |
1983年 | 192篇 |
1982年 | 157篇 |
1981年 | 161篇 |
1980年 | 159篇 |
1979年 | 99篇 |
1978年 | 98篇 |
1977年 | 102篇 |
1976年 | 77篇 |
1975年 | 64篇 |
1974年 | 84篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Bello D Shah DJ Farah GM Di Luzio S Parker M Johnson MR Cotts WG Klocke FJ Bonow RO Judd RM Gheorghiade M Kim RJ 《Circulation》2003,108(16):1945-1953
992.
993.
994.
Nash MJ Camilleri RS Liesner R Mackie IJ Machin SJ Cohen H 《British journal of haematology》2003,120(3):529-531
We report a woman with an obstetric history of a stillbirth at 28 weeks, associated with hypertension and severe intrauterine growth restriction and a miscarriage at 9 weeks. She was persistently positive for immunolgobulin G (IgG) anticardiolipin antibodies and IgG anti-Beta-2-glycoprotein I (anti-Beta2GPI) antibodies. She has delivered three healthy babies when managed antenatally with aspirin and low-molecular-weight heparin prophylaxis. Genotyping revealed that she was homozygous for the 316 Trp to Ser Beta2GPI polymorphism. Studies examining the binding of her plasma Beta2GPI to purified cardiolipin showed markedly reduced binding in comparison with Beta2GPI in pooled normal plasma. 相似文献
995.
Thalidomide and dexamethasone for resistant multiple myeloma 总被引:11,自引:0,他引:11
Anagnostopoulos A Weber D Rankin K Delasalle K Alexanian R 《British journal of haematology》2003,121(5):768-771
Between November 1998 and April 2000, the combination of thalidomide and dexamethasone was evaluated in 47 consecutive patients with multiple myeloma that was resistant to prior high-dose dexamethasone-based therapies. Remission was observed in 22 patients (47%), including six patients with complete remission. Side-effects were frequent, mild and usually reversible, but deep vein thrombosis occurred in 8% of patients. Survival and remission times were longer among patients treated for previous resistant disease rather than for resistant relapse. This experience supports the use of thalidomide-dexamethasone in myeloma patients with resistant disease and justifies further trials in newly diagnosed patients. 相似文献
996.
997.
Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling 总被引:11,自引:0,他引:11
Deng C Lu Q Zhang Z Rao T Attwood J Yung R Richardson B 《Arthritis and rheumatism》2003,48(3):746-756
OBJECTIVE: To determine whether hydralazine might decrease DNA methyltransferase (DNMT) expression and induce autoimmunity by inhibiting extracellular signal-regulated kinase (ERK) pathway signaling. METHODS: The effect of hydralazine on DNMT was tested in vitro using enzyme inhibition studies, and in vivo by measuring messenger RNA (mRNA) levels and enzyme activity. Effects on ERK, c-Jun N-terminal kinase, and p38 pathway signaling were tested using immunoblotting. Murine T cells treated with hydralazine or an ERK pathway inhibitor were injected into mice and anti-DNA antibodies were measured by enzyme-linked immunosorbent assay. RESULTS: In vitro, hydralazine did not inhibit DNMT activity. Instead, hydralazine inhibited ERK pathway signaling, thereby decreasing DNMT1 and DNMT3a mRNA expression and DNMT enzyme activity similar to mitogen-activated protein kinase kinase (MEK) inhibitors. Inhibiting T cell ERK pathway signaling with an MEK inhibitor was sufficient to induce anti-double-stranded DNA antibodies in a murine model of drug-induced lupus, similar to the effect of hydralazine. CONCLUSION: Hydralazine reproduces the lupus ERK pathway signaling abnormality and its effects on DNMT expression, and inhibiting this pathway induces autoimmunity. Hydralazine-induced lupus could be caused in part by inducing the same ERK pathway signaling defect that occurs in idiopathic lupus. 相似文献
998.
The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus 总被引:17,自引:0,他引:17
Anolik JH Campbell D Felgar RE Young F Sanz I Rosenblatt J Looney RJ 《Arthritis and rheumatism》2003,48(2):455-459
OBJECTIVE: Despite wide use of the anti-CD20 monoclonal antibody rituximab in the treatment of B cell lymphomas, the mechanism by which it causes B cell depletion remains a subject of controversy. As part of an ongoing phase I/II trial of rituximab in the treatment of systemic lupus erythematosus (SLE), we sought to determine whether the effectiveness of B cell depletion was influenced by polymorphisms of Fc receptors (FcR) on effector cells. METHODS: During rituximab treatment of 12 SLE patients, B cell depletion was monitored as a function of the serum rituximab level and FcgammaRIIa and FcgammaRIIIa genotypes at baseline and at 1 month and 2 months after treatment. FcR genotypes were determined by polymerase chain reaction. Serum levels of rituximab were measured by enzyme-linked immunosorbent assay (ELISA). B lymphocyte percentages were assessed by flow cytometry. RESULTS: B cell depletion was highly variable in this patient cohort, with B cell percentages at the 1-2-month posttreatment nadir ranging from undetectable (<0.1 cell/microl) to 16% ( approximately 30 cells/microl) of the total peripheral blood lymphocytes. At 2 months posttreatment, B cell percentages were highly correlated with both the serum rituximab level and the FcgammaRIIIa genotype (R(2) = 0.75, P = 0.002). The FcgammaRIIIa genotype was a significant independent predictor of the efficacy of B cell depletion (P = 0.019). CONCLUSION: These results highlight the potential variability of B cell depletion by rituximab in the treatment of autoimmune disease and indicate that Fc receptors are an important determinant of that variability. The findings further suggest the importance of antibody-dependent cell-mediated cytotoxicity and/or apoptosis induction via FcgammaRIIIa-expressing effector cells in the mechanism of B cell depletion by this widely used monoclonal antibody. 相似文献
999.
1000.
Deicken RF Pegues MP Anzalone S Feiwell R Soher B 《The American journal of psychiatry》2003,160(5):873-882
OBJECTIVE: Previous studies attempting to identify neuropathological alterations in the hippocampus in bipolar disorder have been inconclusive. The objective of this study was to determine if the concentration of N-acetylaspartate, a neuronal and axonal marker, was lower in subjects with familial bipolar I disorder than in healthy comparison subjects, suggesting possible neuronal loss, neuronal dysfunction, or neuropil reduction in bipolar I disorder. METHOD: N-acetylaspartate, choline, and creatine in the right and left hippocampus were measured in 15 euthymic male patients with familial bipolar I disorder and 20 healthy male comparison subjects by using proton magnetic resonance spectroscopy ((1)H-MRS). RESULTS: Relative to the comparison group, the patients with bipolar I disorder demonstrated significantly lower concentrations of N-acetylaspartate and creatine but normal choline concentration in both the right and left hippocampus. There were no group or lateralized differences in the percentages of different tissue types within the MRS voxels, suggesting that the hippocampal N-acetylaspartate and creatine alterations were not an artifact of variations in tissue types represented in the voxels. There was also a significant negative correlation between N-acetylaspartate concentration in the right hippocampus and illness duration, after adjustment for the effects of age. CONCLUSIONS: This preliminary study provides support for the existence of neuronal loss, neuronal metabolic dysfunction, or interneuronal neuropil reduction in the hippocampal region in male patients with familial bipolar I disorder. The finding of normal hippocampal choline levels in these patients does not provide support for ongoing myelin breakdown or glial cell proliferation in this brain region in familial bipolar I disorder. The significant association between illness duration and N-acetylaspartate concentration in the right hippocampus supports the idea that neuronal pathology may increase with disease progression and that this effect may be lateralized, involving the right but not the left hippocampus. 相似文献